Parents and children unhappy with traditional education are turning to online alternatives after the pandemic opened the door to new ways of learning
Tax experts warn of potential hit to retirement savings as companies race to calculate impact on costs
It is too early to know whether the prompt response to the virus is enough to turn the tide
Also in this newsletter: How greener corporate car fleets could boost competitiveness and the climate goals
Official report raises questions about cost to taxpayer of pandemic schemes
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
Economy expanded 0.5% in second quarter compared with initial estimate of 0.6%
Emmanuel Hanon criticises former company’s drug after he raises $100mn for rival product
More aggressive actions and better co-ordinated responses needed to contain viruses, say public health experts
Flying blind is dangerous. Technology can build on the basics of local and national data collection
Issue hampers effort to exploit mRNA technology’s promise in tackling deadly viral outbreaks
Early warning system requires roll out of latest testing techniques, Covid levels of co-operation and greater regulatory harmonisation
European Court of Auditors says closer co-operation on data and testing would help fix shortcomings exposed by Covid
Also in this newsletter: Can Brussels block mergers outside of the EU?
Wealthy world must help Africa prevent a potential regional health catastrophe
Chief of Facebook parent says Biden administration was ‘wrong’ and is ready to ‘push back’ in future
Jab makers fall behind Moderna in post-pandemic market with disappointing results
Wild birds are more likely to be carriers of antibiotic-resistant bacteria if they live close to humans, says study
A surge in infections will boost companies’ shares but this sector’s volatility makes them a poor long-term bet
A summer Covid outbreak has left staff wondering if they should skip work, come in, or do something in between
Report finds focus on influenza, preparations for no-deal Brexit and ‘groupthink’ strategy hampered response to virus
EU court rules that European Commission unlawfully withheld information about procurement
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer
